58 structures "https:" "https:" "https:" "https:" "https:" positions at University of Basel in Switzerland
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
encouraged to apply. Application / Contact The application deadline is 31.12.2025, with interviews scheduled in the week of January 5 2026. Where to apply Website https://academicpositions.com/ad/university
-
the project, supported by Dr. Adamo and close collaboration partners, within an environment that encourages academic freedom and scientific independence. In line with our and Uni Basel values (https
-
of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders
-
environment. In line with our and Uni Basel values ( https://www.unibas.ch/en/Research/Values-Ethics/Diversity-and-Inclusion.html ), we are committed to sustain and promote an inclusive culture, ensure equal
-
. The South Africa case study will be based at the Department of History (https://dg.philhist.unibas.ch/de/ ) and the Turkey case study will be based at the Europainstitut / Institute for European Global
-
. The South Africa case study will be based at the Department of History (https://dg.philhist.unibas.ch/de/ ), the Turkey case study at the Europainstitut/Institute for European Global Studies (https
-
cellular biology. The position is available from 1 February 2026. The initial contract will be for one year. For more information on research in the Hondele lab see: https://www.biozentrum.unibas.ch/research
-
This project is flanked by basic reasearch projects i) developing novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary see: https://p3.snf.ch
-
largely understudied global history of fertilizer adoption. The University of Basel will execute two of these case studies. The South Africa case study will be based at the Department of History (https
-
, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary